Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,881,982
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
1,568,958
-
Shares change
-
-204,766
-
Total reported value, excl. options
-
$10,038,360
-
Value change
-
-$1,210,437
-
Put/Call ratio
-
27%
-
Number of buys
-
16
-
Number of sells
-
-11
-
Price
-
$6.40
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q3 2016
40 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q3 2016.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,568,958 shares
of 65,881,982 outstanding shares and own 2.4% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (558,343 shares), Advisor Group, Inc. (306,145 shares), GEODE CAPITAL MANAGEMENT, LLC (125,873 shares), RAYMOND JAMES & ASSOCIATES (90,442 shares), Douglass Winthrop Advisors, LLC (70,540 shares), BlackRock Fund Advisors (53,807 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (46,100 shares), LADENBURG THALMANN FINANCIAL SERVICES INC (45,419 shares), FORTALEZA ASSET MANAGEMENT INC/ (44,900 shares), and BlackRock Institutional Trust Company, N.A. (29,955 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.